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doi:10.1016/j.kjms.2011.11.015Abstract “When should we trigger a transfusion?” is always a critical question between the
patient’s benefits and risks in red blood cell (RBC) transfusion. A computerized transfusion
decision support system (CTDSS) has been used since September 2004 in an academic medical
center with 1400 beds. In this study, the factors affecting RBC transfusion were investigated. In
total 20,551 RBC-transfusion episodes between January and December 2008 were reviewed.
The nearest hemoglobin concentration before transfusion is defined as the transfusion trigger.
The physician compliance, the factors associated with the transfusion triggers and posttrans-
fusion hemoglobin increment were investigated. The physician compliance is 83.1%. The trans-
fusion trigger is 8.32 1.84 (mean standard deviation) g/dL. The transfusion triggers are
statistically significant in terms of both different order sources and disease types
(p< 0.05).The posttransfusion hemoglobin level increased in two-thirds of the episodes. The
percentages of hemoglobin increments after transfusion are dependent on the transfusion
triggers. Appropriate transfusion practice may reduce the overuse of blood components and
improve transfusion quality. CTDSS should be more powerful to intervene in the appropriate-
ness of transfusion practice.
Copyright ª 2012, Elsevier Taiwan LLC. All rights reserved.of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, 100
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(2) acute blood loss exceed 500 mL; (3) patients withRed blood cell (RBC) transfusions have been used clinically
to correct the risks of anemia and increase oxygen delivery
to the body for over 50 years. However, a variety of
transfusion reactions may occur during or after transfusion,
such as febrile nonhemolytic reaction, allergic reactions,
transfusion-related acute lung injury, transfusion associ-
ated graft-versus-host disease, and the transmission of
infectious diseases [1,2]. “When should we trigger a trans-
fusion?” is always a critical question between the patient’s
benefits and risks in RBC transfusion. The status of trans-
fusion triggers for RBC concentrates has been documented
in some studies [3,4], and there have been several guide-
lines for blood transfusion published in the past years
[5e7]. A meta-analysis of several randomized controlled
trials suggests that overall morbidity and mortality, hemo-
dynamic, pulmonary, and oxygen transport variables are
not different between restrictive (transfusion threshold
between 7 g/dL and 8 g/dL) and liberal (transfusion
threshold between 9 g/dL and 10 g/dL) transfusion strate-
gies and that a restrictive transfusion strategy is not asso-
ciated with increased adverse outcomes [3].
In September 2004, a computerized transfusion requi-
sition form was designed in our institution, Kaohsiung
Medical University Hospital (KMUH), an academic medical
center with 1400 beds. The computerized requisition form
would show the criteria of ordered blood component for
the physician to choose before completing the transfusion
order. We have documented the physician compliances
and appropriateness of platelet usage by computerized
transfusion decision support system (CTDSS) [8]. In this
study, we investigate physician compliance, transfusion
trigger from different patient source, and posttransfusion
hemoglobin increment of RBC transfusion by using CTDSS
for the evidence based current RBC transfusion practice
and for improving the performance of CTDSS in a medical
center.Materials and methods
Study data collection
All RBC-transfusion data were retrospectively reviewed
between January and December 2008 from the computer-
ized hospital information system (CHIS) of KMUH. The
demographic data included sex, blood type, type of RBC
concentrate (packed, washed, or leukocyte-poor RBC),
admission type of service (patient source and functional
unit), and the transfusion indication chosen from CTDSS.
The patients’ nearest hemoglobin levels within 5-day
before and after transfusions were retrieved from the
laboratory information system database. The “true reason”
for each transfusion practice was obtained from CHIS.
Criteria of RBC transfusion in KMUH
The hospital’s RBC-usage criteria that were established by
the KMUH transfusion committee and used as a computer-
ized transfusion guide are as follows: (1) preoperativeanemia (hemoglobin level < 9 g/dL or hematocrit <27%);
chronic anemia combined with anemic signs and symptoms,
including postural hypotension or tachycardia, exertional
dyspnea, confusion, and lethargy; and (4) others. The
physician would choose one of the above criteria from
CTDSS before completing a RBC-transfusion order.
Investigate the transfusion triggers of RBC
concentrates
The transfusion trigger of each transfusion episode was
investigated according to the nearest hemoglobin level
before transfusion. Factors associated with the RBC trans-
fusion triggers, including the patient sources, the func-
tional units, and the disease types, were also investigated.
The patient sources are classified into three categories,
which include emergency department (ED), inpatient
department (IPD), and outpatient department. By the
functional units, we classify the episodes into four cate-
gories: internal medicine, pediatrics, surgery and emer-
gency. Based on the disease types, the episodes are
classified into three groups: hematological malignancies,
nonhematological malignancies, and all other diseases.
These factors were analyzed by ANOVA tests, and p values
of less than 0.05 were considered to be statistically
significant.
Results
Episode characteristics
Between January and December 2008, there were 20,551
episodes of RBC transfusion ordered. The distribution of
RBC-transfusion episodes during this 1-year period is
shown in Table 1. The male:female ratio is about 3:2
(57.7% vs. 42.3%), and the O blood type is predominant
(42.4%) in all the episodes. Almost all episodes (96.1%)
ordered packed RBC concentrates, and washed RBC and
leukocyte-poor RBC were ordered 1915 units (4.4%) and
132 unit (0.3%), respectively. In admission type of service,
73.8% episodes are from IPD, and near half (44.7%) are
from internal medicine unit. The percentage of episodes
ordered from pediatrics unit, surgery unit, and ED are 9.8,
29.6, and 15.9%, respectively. Five hundred and fifty-seven
(2.7%) episodes are without hemoglobin data before
transfusions. Eighty-one episodes ordered RBC transfusions
even with pretransfusion hemoglobin level of more than
15 g/dL.
The percentage of the indication from CTDSS
The percentage of the indication for RBC transfusion from
the CTDSS is shown in Table 2. The first common indication
for RBC transfusion chosen from CTDSS is “Acute blood loss
exceeds 500 mL.” (nZ 8049; 39.1%), and the second is
“Patients with chronic anemia combined with anemic signs
and symptoms.” (nZ 5313; 25.9%). There are 3467 (16.9%)
episodes without any indication chosen from CTDSS, when
ordering.
Table 1 Distribution of red blood cell (RBC) transfusion.
Characteristics Episodea (nZ 20,551) Unitb (nZ 43,918)
Sex Male 11,865 (57.7) 25,912 (59.0)
Female 8686 (42.3) 18,006 (41.0)
ABO type O 8712 (42.4) 18,827 (42.9)
A 5734 (27.9) 12,244 (27.9)
B 4706 (22.9) 9794 (22.2)
AB 1399 (6.8) 3053 (7.0)
RBC type Packed RBC 19,747 (96.1) 41,871 (95.3)
Washed RBC 770 (3.7) 1915 (4.4)
Leukocyte-poor RBC 34 (0.2) 132 (0.3)
Source Emergency department (ED) 3260 (15.9) 7109 (16.2)
Inpatient department (IPD) 15,180 (73.8) 31,396 (71.5)
Outpatient department (OPD) 2111 (10.3) 5413 (12.3)
Functional units Internal medicine Nonhematology 6926 (33.7) 13,850 (31.5)
Hematology 2257 (11.0) 4643 (10.6)
Pediatrics Nonhematology 679 (3.3) 871 (2.0)
Hematology 1339 (6.5) 3669 (8.4)
Surgery 6090 (29.6) 13,792 (31.4)
Hemoglobin level (pretransfusion) Emergency 3260 (15.9) 7093 (16.2)
No data 557 (2.7) 1312 (3.0)
& 7 g/dL 4156 (20.2) 9073 (20.7)
＞7 e & 9 g/dL 10,411 (50.7) 20,853 (47.5)
＞9 e &10 g/dL 2627 (12.8) 5678 (12.9)
＞10 e & 15 g/dL 2719 (13.2) 6786 (15.5)
＞15 g/dL 81 (0.4) 216 (0.5)
a,b Data are reported as number (%).
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concentrates
The transfusion trigger of all RBC transfusion episodes is
8.32 1.84 (mean standard deviation) g/dL. The factors
associated with the RBC transfusion triggers are shown in
Table 3. For the sources of RBC-transfusion orders, the
transfusion trigger is lowest in the ED, 7.98 2.22 g/dL,
and highest in the IPD, 8.41 1.72 g/dL. For the functional
units of RBC transfusion, the mean of transfusion triggers in
the emergency, internal medicine, surgery, and pediatric
units are 7.98, 7.91, 8.93, and 8.95 g/dL, respectively. ForTable 2 The percentage of indications for red blood cell
transfusion from CTDSS (nZ 20551).
Episodesa
Valid 17,084 (83.1)
Preoperative anemia (hemoglobin
level <9 g/dL or hematocrit <27%)
2299 (11.1)
Acute blood loss exceed 500 mL 8049 (39.1)
Patients with chronic anemia
combined with anemic signs
and symptomsb
5313 (25.9)
Others 1423 (7.0)
Not valid 3467 (16.9)
a Data are reported as number (%).
b Anemic signs and symptoms include postural hypotension or
tachycardia, exertional dyspnea, confusion and lethargy.the disease type, the transfusion trigger is lowest in the
hematological malignancies with a mean of 7.90 1.61 g/
dL. Statistically significant differences analyzed by ANOVA
tests are observed in the order of both the sources and the
disease types (p< 0.05). However, in the functional units,
there are only statistically significant differences observed
between (1) emergency and surgery; (2) emergency and
pediatrics; (3) internal medicine and surgery; and (4)
internal medicine and pediatrics (p< 0.05, data not
shown).
Hemoglobin level increment after transfusion
We evaluated the posttransfusion hemoglobin increments of
the episodes chosen on indication from CTDSS (Table 4).
After excluding 3783 episodes without posttransfusion
hemoglobin data within 5 days after transfusion, there are
16,211 episodes in this analysis. The pre- and posttransfusion
hemoglobin levels were measured in 0.27 0.68 (mean -
 standard deviation) days and 1.61 1.1 days, respec-
tively. After comparing the hemoglobin data during pre- and
posttransfusions, hemoglobin levels increased in 1346
episodes (82.8%) after transfusions. Hemoglobin levels
decreased in 2795 (17.2%) episodes even after transfusions.
The percentages of RBC increment for each subgroup of
pretransfusion hemoglobin level less than 7 g/dL, between
7 g/dL and 9 g/dL, between 9 g/dL and 10 g/dL, and more
than 10 g/dL are 94.6%, 90.9%, 70.6% and 41.3%, respec-
tively. In addition, themean of hemoglobin increase for each
subgroup are 2.15, 1.62, 1.41 and 0.55 g/dL, respectively.
Table 3 Transfusion triggers for red blood cell (RBC) concentrates (nZ 19,994).
RBC transfusion episodes Pretransfusion hemoglobina (g/dL)
Source Emergency department (ED) 3241 (16.2%) 7.98 2.22
Inpatient department (IPD) 14,901 (74.5%) 8.41 1.72
Outpatient department (OPD) 1852 (9.3%) 8.18 1.94
Functional unit Emergency 3234 (16.2%) 7.98 2.22
Internal medicine 9068 (45.3%) 7.91 1.50
Surgery 5882 (29.4%) 8.93 1.90
Pediatrics 1810 (9.1%) 8.95 1.72
Disease type Hematooncologic malignancies 3434 (17.2%) 7.90 1.61
Nonhematologic malignancies 1142 (5.7%) 8.19 1.50
All other diseases 15,418 (77.1%) 8.42 1.90
a Data are reported as mean  standard deviation.
334 C.-S. Chang et al.Discussion
The first common indication for RBC transfusion chosen
from CTDSS is “Acute blood loss exceed 500 mL” (nZ 8049;
39.1%), and the second is “Patients with chronic anemia
combined with anemic signs and symptoms” (nZ 2299;
11.1%). Physician incompliance of RBC transfusion in our
study could be defined, as the physician chose the “no”
indication when ordering transfusion, and there are 3467
(16.9%) episodes performed without choosing any indica-
tion from CTDSS, moreover, 557 episodes without pre-
transfusion hemoglobin data when ordering in our study. As
we described in the study of platelet and fresh frozen
plasma usage by CTDSS [8,9], a noncompliant transfusion
order does not always mean an unnecessary usage. A non-
compliant episode might be a necessary transfusion if the
clinical status satisfies the blood component-usage criteria,
but does not pick any indication by the physician from
CTDSS, when ordering.
Most clinicians decided to transfuse depending on the
hemoglobin concentrate. Because of the absence of reli-
able clinical findings or tests to indicate the need for
transfusion, hemoglobin data as the most important factor
to guide when need to transfusion by clinicians isTable 4 Evaluation of posttransfusion hemoglobin increment (n
Posttransfusion
hemoglobin
increment (compared
with pretransfusion)
Episod
Pretransfusion he
&7 ＞7e9
Hemoglobin decrease 172 802
Hemoglobin increase 3108
(3108/3280Z 94.6%)
7993
(7993/8795Z 90.9%
Hemoglobin
increasea (g/dL)
2.15 1.46 1.62 1.02
&1.0 611 2352
>1.0e2.0 1102 3374
>2.0 1395 2267
Transfusion unita 2.16 0.78 1.99 0.58
Total
a Data are reported as mean  standard deviation.reasonable [4]. In our study, the transfusion trigger of all
RBC transfusion episodes is 8.32 1.84 (mean standard
deviation) g/dL. For the source of RBC-transfusion orders,
the transfusion trigger is highest in the IPD (mean -
 standard deviationZ 8.41 1.72 g/dL, Table 3). It might
be because a part of transfusion episodes from IPD are
ordered for the preoperative preparation of major surgery.
This is compatible with the analysis by the function units.
The mean of transfusion triggers in the surgery department
is higher than in the emergency and the internal medicine
departments (8.93, 7.98 and 7.91 g/dL, respectively) and it
has statistically significant differences by ANOVA tests
(p< 0.05). The mean of transfusion triggers are similar
between the surgery and the pediatric departments (8.93
and 8.95 g/dL, respectively). In children and infant babies,
they often need higher hemoglobin concentrates than the
adults to maintain the oxygen delivery to the bodies.
For posttransfusion increment, the hemoglobin levels
increased after transfusions in 13,416 episodes (82.8%) in
which pre- and posttransfusion hemoglobin data were
retrieved. The percentages of RBC increment for each
subgroup of pretransfusion hemoglobin level less than
7 g/dL, between 7 g/dL and 9 g/dL, between 9 g/dL and
10 g/dL, and more than 10 g/dL are 94.6%, 90.9%, 70.6% andZ 16,211).
e numbers Total (%)
moglobin level (g/dL)
＞9e10 ＞10
608 1213 2795 (17.2)
)
1460
(1460/2068Z 70.6%)
855
(855/2068Z 41.3%)
13,416 (82.8)
1.41 0.97 0.55 0.36 0.75 0.33
403 484 3850 (28.7)
753 245 5474 (40.8)
304 126 4092 (30.5)
2.02 0.79 1.69 0.53
16,211 (100)
Factors affecting RBC transfusion 33541.3%, respectively. In addition, the mean of hemoglobin
increase for each subgroup are 2.15, 1.62, 1.41, and
0.55 g/dL, respectively (Table 4). The percentages of RBC
increment episodes and the mean of increased hemoglobin
concentrates seemed to be dependent on the transfusion
triggers. Some studies evaluating RBC transfusion thresh-
olds in critical care documented that there were no
significant differences between “liberal” and “restrictive”
transfusion groups in long-term mortality, infections, or
days on ventilator [10e13]. These studies also reported
that the group with lower hemoglobin had a lower rate of
cardiovascular complications, such as myocardial infarction
or congestive heart failure than the higher hemoglobin.
Outcomes were much similar in “liberal” and “restrictive”
transfusion groups of patients but it associated with a 44%
drop in the number of red-cell transfusions [13,14]. These
findings suggest that many RBC transfusions might be
unnecessary.
It has been demonstrated that computerized decision
system is an effective tool to improve physician perfor-
mance, criteria compliance, and patient outcome [15]. As
description in platelet usage, CTDSS could help the
ordering physician to remind him of the transfusion
appropriateness, but it has no power to reject the trans-
fusion requisition without picking any indication or without
checking pretransfusion laboratory data (such as platelet
counts, hemoglobin concentrates) when ordering [8].
Eighty-one RBC transfusion practices in this study still
administered even with pretransfusion hemoglobin levels of
more than 15 g/dL. These episodes were from IPD (nZ 47,
58%) and ED (nZ 34, 42%). Moreover, in the subgroups of
functional units from IPD, 29 (35.8%) episodes were ordered
from the surgery department. It might be associated with
the physicians’ transfusion knowledge, the urgent evalua-
tion of patient, and unstable nature of ED or surgical
patients.
We suggest a criteria when accepting a computerized
transfusion order should be established, such as an indi-
cation must be chosen before completing the transfusion
order and the pretransfusion hemoglobin should be
checked and be less than shown on the computerized RBC
concentrate requisition form. If the transfusion indication
is not chosen or the pretransfusion hemoglobin level is not
appropriate for RBC transfusion, the order would be
blocked by CTDSS. It might make the CTDSS more func-
tional and effective to prevent some inappropriate trans-
fusions and reduce unnecessary transfusion practice.
We set an indication as “others” for the physician to
choose in CTDSS if there is no indication suitable to clinical
condition, and the blood bank would contact the ordering
physician to evaluate the transfusion necessary before
accepting the computerized transfusion requisition. This
might allow CTDSS some flexibility although it might be
difficult in smaller community hospitals where the blood
bank is often operated without an extensive medical staff
support to contact the physician. Most RBC transfusion
triggers in our institution were acceptable, although some
transfusion practices were still performed even when the
pretransfusion hemoglobin level was within normal range,
possibly due to urgent clinical conditions.Computerization would be a trend in medical manage-
ment system to improve physician performance and
improve the medical quality, but the CTDSS should be more
powerful and effective to intervene in our transfusion
practice. Appropriate transfusion practice may reduce the
overuse of blood components, avoid transfusion risks,
decrease hospital costs, and improve transfusion quality.
Further studies are warranted to investigate the efficacy of
the CTDSS application for making decisions regarding clin-
ical RBC transfusion.References
[1] Alter HJ, Klein HG. The hazards of blood transfusion in
historical perspective. Blood 2008;112:2617e26.
[2] Davenport RD, Miniz Pincus PD. Henry’s clinical diagnosis and
management by laboratory methods. In: McPherson RA,
Pincus MR, editors. Transfusion medicine. Philaadelphia:
Elsevier; 2007.
[3] Hardy JF. Current status of transfusion triggers for red blood
cell concentrates. Transfus Apher Sci 2004;31:55e66.
[4] Carson JL, Kuriyan M. What should trigger a transfusion?
Transfusion 2010;50:2073e5.
[5] Practice guidelines for blood component therapy: A report by
the American Society of Anesthesiologists Task Force on Blood
Component Therapy. Anesthesiology 1996;84:732e747.
[6] Crosby E, Ferguson D, Hume HA, Kronick JB, Larke B, Leblond P,
et al. Guidelines for red blood cell and plasma transfusion for
adults and children. Can Med Assoc J 1997;156:S1e24.
[7] Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS,
Tisherman SA, et al. Clinical practice guideline: red blood cell
transfusion in adult trauma and critical care. Crit Care Med
2009;37:3124e57.
[8] Lin YC, Chang CS, Yeh CJ, Wu YC. The appropriateness and
physician compliance of platelet usage by a computerized
transfusion decision support system in a medical center.
Transfusion 2010;50:2565e70.
[9] Chang CS, Lin YC, Wu YC, Yeh CJ, Lin YC. The effects of
a computerized transfusion decision support system on physi-
cian compliance and its appropriateness for fresh frozen
plasma use in a medical center. Am J Clin Pathol 2011;135:
417e22.
[10] He´bert PC, Wells G, Blajchman MA, Marshall J, Martin C,
Pagliarello G, et al. A multicenter, randomized, controlled
clinical trial of transfusion requirements in critical care.
Transfusion requirements in critical care investigators, Cana-
dian critical care trials group. N Engl J Med 1999;340:409e17.
[11] He´bert PC, Blajchman MA, Cook DJ, Yetisir E, Wells G,
Marshall J, et al. Do blood transfusions improve outcomes
related to mechanical ventilation? Chest 2001;119:1850e7.
[12] Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A,
et al. Anemia and blood transfusion in critically ill patients.
JAMA 2002;288:1499e507.
[13] Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in
clinical practice. Lancet 2007;370:415e26.
[14] Carless PA, Henry DA, Carson JL, Hebert PP, McClelland B,
Ker K. Transfusion thresholds and other strategies for guiding
allogeneic red blood cell transfusion. Cochrane Database Syst
Rev 2010;10:CD002042.
[15] Salem-Schatz SR, Avorn J, Soumerai SB. Influence of clinical
knowledge, organizational context and practice style on
transfusion decision making: implications for practice change
strategies. J Am Med Assoc 1990;264:476e83.
